10/9 MannKind: Rise On Affreza Label Revision Acceptance •Afreezza script sales rise to over 440. •Script sales for the quarter come in at nearly 4,900. •Stock has risen sharply on FDA acceptance of label revision https://seekingalpha.com/article/4112400-mannkind-afrezza-sales-rise-along-stock-price?auth_param=1vat:1ctmrsu:5f5b5991d1659bdb2daf89591a41866a&uprof=51#alt3